Clinical Trial: Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Prophylaxis of Bronchopulmonary Dysplasia With Clarithromycin

Brief Summary: The purpose of this study is to determine of clarithromycin effect on developing of bronchopulmonary dysplasia in preterm babies.

Detailed Summary:

The investigators planned that clarithromycin treatment in preterm babies who are under 1250 grams birth weight.

The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm babies may decrease.


Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital

Current Primary Outcome: Bronchopulmonary dysplasia [ Time Frame: 28. day of birth ]

On the 28. day of birth, The investigator will determine the baby whether has developed bronchopulmonary dysplasia


Original Primary Outcome: Same as current

Current Secondary Outcome: Overall survival [ Time Frame: Participants will be followed for the duration of hospital stay, an expected average of postnatal 40 weeks ]

During to hospitalisation the investigator will determine and record some co-morbidities of BPD such as intracranial hemorrhage, necrotizing enterocolitis, patent ductus arteriosus rates.From date of randomization until the end of the hospitalisation up to the 3 months of life.


Original Secondary Outcome: Same as current

Information By: Zekai Tahir Burak Women's Health Research and Education Hospital

Dates:
Date Received: July 22, 2012
Date Started: October 2011
Date Completion: January 2013
Last Updated: July 26, 2012
Last Verified: July 2012